Barry E. Greene - 19 May 2022 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
Director
Signature
/s/ Nancy Smith, Attorney-in-Fact for Barry Greene
Issuer symbol
KPTI
Transactions as of
19 May 2022
Net transactions value
$0
Form type
4
Filing time
20 May 2022, 16:02:28 UTC
Previous filing
15 Feb 2022
Next filing
15 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KPTI Nonstatutory Stock Option (right to buy) Award $0 +23,900 $0.000000 23,900 19 May 2022 Common Stock 23,900 $5.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests as to 100% of the underlying shares on the earlier of May 19, 2023 or the next annual meeting of stockholders of Karyopharm Therapeutics Inc.